Variation of the choline signal intensity in the dorsolateral prefrontal cortex of rats exposed to the forced swimming test as detected by in vivo 1H MR spectroscopy

Journal of Neuroscience Methods

Volumn 165, Issue 1, 2007, Pages 89-94

  Hong, Sung Tak ^a   Choi, Chi Bong ^a   Park, Cheongsoo ^b   Hong, Kwan Soo ^b   Cheong, Chaejoon ^b   Jeon, Yang Whan ^c   Choe, Bo Young ^a  

^a The Catholic University of Korea   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Our Lady of Mercy Hospital   (South Korea)

Author keywords

1H magnetic resonance spectroscopy (MRS); Depression; Dorsolateral prefrontal cortex (DLPFC); Forced swimming test (FST)

Indexed keywords

CHOLINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; IN VIVO STUDY; MALE; MENTAL HEALTH; METABOLITE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ASPARTIC ACID; CHOLINE; CREATINE; DEPRESSION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL;

EID: 34447518621     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.05.022     Document Type: Article

References (33)

1. Auer D.P., Putz B., Kraft E., Lipinski B., Schill J., and Holsboer F. Reduced glutamate in the anterior dingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47 (2000) 305-313
2. Bae J.N., MacFall J.R., Krishnan K.R.R., Payne M.E., Steffens D.C., and Taylor W.D. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry 60 (2006) 1356-1363
3. Binesh N., Kumar A., Hwang S., Mintz J., and Albert Thomas M. Neurochemistry of late-life major depression: a pilot two-dimensional MR spectroscopic study. J Magn Reson Imaging 20 (2004) 1039-1045
4. Byrum C.E., Ahearn E.P., and Krishnan K.R.R. A neuroanatomic model for depression. Prog Neuropsycho-pharmacol Biol Psychiatry 23 (1999) 175-193
5. Carlezon Jr. W.A., Pliakas A.M., Parow A.M., Detke M.J., Cohen B.M., and Renshaw P.F. Antidepressant-like effects of cytidine in the forced swimming test in rats. Biol Psychiatry 51 (2002) 882-889
6. Chang K., Adleman N., Dienes K., Barnea-Goraly N., Reiss A., and Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 53 (2003) 1059-1065
7. Charles H.C., Lazeyras F., Krishnan K.R.R., Boyko O.B., Payne M., and Moore D. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsycho-pharmacol Biol Psychiatry 18 (1994) 1121-1127
8. Coupland N.J., Ogilvie C.J., Hegadoren K.M., Seres P., Hanstock C.C., and Allen P.S. Decreased prefrontal myo-inositol in major depressive disorder. Biol Psychiatry 57 (2005) 1526-1534
9. Detke M.J., Johnson J., and Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5 (1997) 107-112
10. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
11. Drevets W.C., Bogers W., and Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12 (2002) 527-544
12. Duc C.O., Weber A.H., Trabesinger A.H., Meier D., and Boesiger P. Recycling the cholines. Int Soc Magn Reson Med 6 (1997) 1210
13. Ende G., Braus D.F., Walter S., Weber-Fahr W., and Henn F.A. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 57 (2000) 937-943
14. Espejo E.F., and Minano F.J. Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during porsolt's test. Neuroscience 88 (1999) 609-615
15. Farchione T.R., Moore G.J., and Rosenberg D.R. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry 52 (2002) 86-92
16. Galynker I.I., Cai J., Ongseng F., Finestone H., Dutta E., and Serseni D. Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med 39 (1998) 608-612
17. 1H-MRS at 3 Tesla. Invest Radiol 38 (2003) 403-408
18. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 29 (1993) 804-811
19. Haydon P.G. Glia: listening and talking to the synapse. Nat Rev Neurosci 2 (2001) 185-193
20. Janowsky D.S., El-Yousef M.K., Davis J.M., and Sekerke H.J. A cholinergicadrenergic hypothesis of mania and depression. Lancet 2 (1972) 632-635
21. Kumar A., Thomas A., Lavretsky H., Yue K., Huda A., Curran J., et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 159 (2002) 630-636
22. Mason G.F., and Krystal J.H. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. NMR Biomed 19 (2006) 690-701
23. Muigg P., Hoelzl U., Palfrader K., Neumann I., Wigger A., Landgraf R., et al. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry 61 (2007) 782-796
24. Nolan C.L., Moore G.J., Madden R., Farchione T., Bartoi M., Lorch E., et al. Prefrontal cortical volume in childhood-onset major depression. Arch Gen Psychiatry 59 (2002) 173-179
25. Petroff O.A.C., Ogino T., and Alger J.R. High resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J Neurochem 51 (1988) 163-171
26. Porsolt R.D., Pichon MLe, and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
27. Quintana J., and Fuster J.M. From perception to action: temporal integrative functions of prefrontal and parietal neurons. Cereb Cortex 9 (1999) 213-221
28. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45 (1999) 1085-1098
29. Renshaw P.F., Lafer B., Babb S.M., Fava M., Stoll A.L., Christensen J.D., et al. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 41 (1997) 837-843
30. Soares J.C., and Mann J.J. The anatomy of mood disorders-review of structural neuroimaging studies. Biol Psychiatry 41 (1997) 86-106
31. Steingard R.J., Yurgelun-Todd D.A., Hennen J., Moore J.C., Moore C.M., Vakili K., et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry 48 (2000) 1053-1061
32. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 (1993) 981-989
33. Vythilingam M., Charles H.C., Tupler L.A., Blitchington T., Kelly L., and Krishnan K.R.R. Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry 54 (2003) 744-750